These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Developmental pharmacology. van den Anker JN Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761 [TBL] [Abstract][Full Text] [Related]
7. Developmental Changes in Pharmacokinetics and Pharmacodynamics. van den Anker J; Reed MD; Allegaert K; Kearns GL J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S10-S25. PubMed ID: 30248190 [TBL] [Abstract][Full Text] [Related]
8. Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children. Vinks AA; Emoto C; Fukuda T Clin Pharmacol Ther; 2015 Sep; 98(3):298-308. PubMed ID: 26073179 [TBL] [Abstract][Full Text] [Related]
9. Study design and simulation approach. Läer S; Meibohm B Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109 [TBL] [Abstract][Full Text] [Related]
10. In vitro ADME phenotyping in drug discovery: current challenges and future solutions. Williams JA; Bauman J; Cai H; Conlon K; Hansel S; Hurst S; Sadagopan N; Tugnait M; Zhang L; Sahi J Curr Opin Drug Discov Devel; 2005 Jan; 8(1):78-88. PubMed ID: 15679175 [TBL] [Abstract][Full Text] [Related]
11. Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science. Leeder JS; Kearns GL; Spielberg SP; van den Anker J J Clin Pharmacol; 2010 Dec; 50(12):1377-87. PubMed ID: 20150527 [TBL] [Abstract][Full Text] [Related]
12. Ontogeny of oral drug absorption processes in children. Mooij MG; de Koning BA; Huijsman ML; de Wildt SN Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526 [TBL] [Abstract][Full Text] [Related]
13. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development. Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796 [TBL] [Abstract][Full Text] [Related]
14. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy. Rodieux F; Gotta V; Pfister M; van den Anker JN J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Evans WE; Johnson JA Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642 [TBL] [Abstract][Full Text] [Related]
16. Optimizing pediatric dosing: a developmental pharmacologic approach. Anderson GD; Lynn AM Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy in childhood: what has been done and what has to be done? Bartels H Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868 [TBL] [Abstract][Full Text] [Related]
18. Developmental pharmacology--drug disposition, action, and therapy in infants and children. Kearns GL; Abdel-Rahman SM; Alander SW; Blowey DL; Leeder JS; Kauffman RE N Engl J Med; 2003 Sep; 349(12):1157-67. PubMed ID: 13679531 [No Abstract] [Full Text] [Related]
20. Individualizing the use of medications in children: making Goldilocks happy. Leeder JS; Brown JT; Soden SE Clin Pharmacol Ther; 2014 Sep; 96(3):304-6. PubMed ID: 24926777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]